...
首页> 外文期刊>Behavioural pharmacology >Effects of monoamine releasers with varying selectivity for releasing dopamineorepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys.
【24h】

Effects of monoamine releasers with varying selectivity for releasing dopamineorepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys.

机译:具有不同选择性的多胺单释放剂释放多巴胺/去甲肾上腺素对血清素的作用对恒河猴可卡因和食物选择的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Monoamine releasers constitute one class of candidate medications for the treatment of cocaine abuse, and concurrent cocaine-versus-food choice procedures are potentially valuable as experimental tools to evaluate the efficacy and safety of candidate medications. This study assessed the choice between cocaine and food by rhesus monkeys during treatment with five monoamine releasers that varied in selectivity to promote the release of dopamine and norepinephrine versus serotonin (5HT) [m-fluoroamphetamine, (+)-phenmetrazine, (+)-methamphetamine, napthylisopropylamine and (+/-)-fenfluramine]. Rhesus monkeys (n=8) responded under a concurrent-choice schedule of food delivery (1-g pellets, fixed ratio 100 schedule) and cocaine injections (0-0.1 mg/kg/injection, fixed ratio 10 schedule). Cocaine choice dose-effect curves were determined daily during continuous 7-day treatment with saline or with each test compound dose. During saline treatment, cocaine maintained a dose-dependent increase in cocaine choice, and the highest cocaine doses (0.032-0.1 mg/kg/injection) maintained almost exclusive cocaine choice. Efficacy of monoamine releasers to decrease cocaine choice corresponded to their pharmacological selectivity to release dopamine and norepinephrine versus 5HT. None of the releasers reduced cocaine choice or promoted reallocation of responding to food choice to the same extent as when saline was substituted for cocaine. These results extend the range of conditions across which dopamine and norepinephrine-selective releasers have been shown to reduce cocaine self-administration.
机译:单胺释放剂构成一类用于治疗可卡因滥用的候选药物,同时进行的可卡因与食物的选择程序作为评估候选药物功效和安全性的实验工具具有潜在的价值。这项研究评估了恒河猴在用五种单胺释放剂治疗期间可卡因和食物之间的选择,这些释放剂的选择性各不相同,以促进多巴胺和去甲肾上腺素相对于血清素(5HT)[间-氟苯丙胺,(+)-苯甲r嗪,(+)-甲基苯丙胺,萘异丙胺和(+/-)-芬氟拉明]。恒河猴(n = 8)在同时选择食物递送(1-g颗粒,固定比例为100的时间表)和可卡因注射液(0-0.1 mg / kg /注射,固定比例为10的时间表)下做出反应。在连续7天用盐水或每种受试化合物剂量治疗期间,每天测定可卡因选择剂量效应曲线。在盐水治疗期间,可卡因在可卡因选择中维持剂量依赖性增加,而最高可卡因剂量(0.032-0.1 mg / kg /针剂)几乎维持唯一的可卡因选择。单胺释放剂减少可卡因选择的功效与其释放5p相比释放多巴胺和去甲肾上腺素的药理选择性相对应。没有任何一种释放剂可以减少可卡因的选择或促进对食物选择的反应的重新分配,其程度与用生理盐水代替可卡因时的释放程度相同。这些结果扩大了多巴胺和去甲肾上腺素选择性释放剂可减少可卡因自我给药的条件范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号